4//SEC Filing
Ellias Helen K. 4
Accession 0001193125-25-324976
CIK 0001833214other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:45 PM ET
Size
5.5 KB
Accession
0001193125-25-324976
Insider Transaction Report
Form 4
Ellias Helen K.
Director
Transactions
- Award
Stock Option (right to buy)
2025-12-16+150,000→ 150,000 totalExercise: $3.99Exp: 2035-12-16→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest in two equal annual installments on December 16, 2026 and December 16, 2027.
- [F2]This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.
Documents
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeother
Related Parties
1- filerCIK 0002001600
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 4:45 PM ET
- Size
- 5.5 KB